Quantitative analysis of survivin in colorectal adenocarinoma: increased expression and correlation with telomerase activity
Lam, Alfred King-Yin, Saleh, Said, Smith, Robert Anthony, and Ho, Yik-Hong (2008) Quantitative analysis of survivin in colorectal adenocarinoma: increased expression and correlation with telomerase activity. Human Pathology, 39 (8). pp. 1229-1233.
|PDF (Published Version) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: http://dx.doi.org/10.1016/j.humpath.2008...
The aims of the present study are to quantitatively analyze survivin expression, its clinicopathologic roles, and correlation with telomerase activity in a large cohort of patients with colorectal adenocarcinoma. Real-time polymerase chain reaction was used to quantitate expression level of survivin messenger RNA and human telomerase reverse transcriptase messenger RNA (telomerase activity) in 51 patients with colorectal adenocarcinomas. The findings were correlated with the clinicopathologic features of patients, which were prospectively collected into a computerized database. Survivin messenger RNA was expressed in all tumor samples. The level of expression in tumor tissues was increased in comparison with matched nontumor mucosa in the same patient (P = .01). The level of expression of survivin was significantly correlated with the level of human telomerase reverse transcriptase expression (P = .008) and size of the colorectal adenocarcinomas (P = .004). Survival of the patients with colorectal adenocarcinoma was associated with the TNM stages (P = .001) and not with the level of expression of survivin. Thus, survivin activity was altered in colorectal adenocarcinoma. The high prevalence of survivin expression and correlation with telomerase activity are important factors for consideration in gene targeting therapy for colorectal adenocarcinoma.
|Item Type:||Article (Refereed Research - C1)|
|Keywords:||survivin; telomerase; colorectal adenocarcinoma|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1112 Oncology and Carcinogenesis > 111201 Cancer Cell Biology @ 100%|
|SEO Codes:||92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920102 Cancer and Related Disorders @ 100%|
|Deposited On:||22 Jan 2010 11:03|
|Last Modified:||11 Jun 2013 00:56|
Last 12 Months: 0
|Citation Counts with External Providers:||Web of Science: 6|
Repository Staff Only: item control page